
<!DOCTYPE html>
<html>
<head>
  <title> Entrance exams </title>
</head>
<meta charset="utf-8">
<meta name="viewport" content="width=device-width, initial-scale=1">

<style>
{
padding:0;
margin:0;
}



body
{
background-image: url(Background.jpg);
background-color: #cccccc;
height: 500px;
background-position: center;
background-repeat: no-repeat;
background-size: cover;
position: relative;
}

.header {background-color: ;
padding: 20px;
text-align: center;
}
.menu-bar
{
background: rgb(50, 100, 0);
text-align: center;
}
.menu-bar ul
{
display: inline-flex;
list-style: none;
color: #fff
}
.menu-bar ul li
{
width: auto;
margin: 5px;
padding: 10px;
}
.menu-bar ul li a
{text-decoration: none;
color: #fff}
.active, .menu-bar ul li:hover
{
background: #2bab0d;
border-radius: 3px;
}
.menu-bar .fa
{ margin-left: 8px;
}

#mySidenav a {
position: absolute;
left: -140px;
transition: 0.3s;
padding: 15px;
width: 150px;
text-decoration: none;
font-size: 20px;
color: white;
border-radius: 0 5px 5px 0;
}
#mySidenav a:hover {
left: 0;
}
#about {
top: 270px;
background-color: #f44336;
}
#blog {
top: 370px;
background-color: #555;
}
#projects {
top: 470px;
background-color: #2196F3;
}
#contact {
top: 570px;
background-color: #4CAF50;
}


h3
{background-color: Pink;
color: Black;
width: 80%;
margin: 80px;
padding:20px;}
ul.a
{background-color: Pink;
color: Blue;
width: 80%;
margin: 80px;
padding:20px;}

ul.b
{background-color: lightblue;
color: Red;
width: 75%;
margin-left: 50px;
padding: 20px;
}

ul.c
{background-color: lightgreen;
color:Black;
width: 70%;
margin-left: 50px;
padding:20px ;
}

</style>
<body>

  <div class="header">
  <h1> Pharma Vision- Syllabus </h1>


<p> One should study in detail to have command over all basic concepts </p>
</div>
<div class="menu-bar">
  <ul>

  <li ><a href="index.html"> Main page </a></li>
  <li><a href="Syllabusandcontent.html"> Syllabus and content</a> </li>
  <li><a href="#"> Points to be remembered </a></a></li>
  <li><a href="#"> Study outline </a></li>
  <li><a href="#"> Reference </a></li>
</div>

<div id="mySidenav" class="sidenav">
  <a href="meliorate.html" id="about">Aptitude </a>
  <a href="pharmavision.html" id="blog">Gov. Exam</a>
  <a href="smallbreak.html" id="projects">MBA EE</a>
  <a href="thinkingpot.html" id="contact">Others</a>
</div>


<h3> GPAT- Pharmaceutical Analysis </h3>
<ul class="a">
<li><a href="#">Pharmaceutical Chemistry</a></li>
<ul class="b">
<li><a href="#">Pharmaceutical Impurities</a></li>
<ul class="c">
  <li><a href="#">Impurities in pharmaceutical substances, sources, types & effects of impurities</a></li>
  <li><a href="#">Limit tests for heavy metals as per Indian Pharmacopoeia [I. P.]</a></li>
  <li><a href="#">lead</a></li>
  <li><a href="#">iron</a></li>
  <li><a href="#">arsenic</a></li>
  <li><a href="#">mercury</a></li>
  <li><a href="#">chloride</a></li>
  <li><a href="#">sulphate</a></li>
</ul>

<li><a href="#">Monographs</a></li>
<ul class="c">
  <li><a href="#">Monograph & its importance</a></li>
  <li><a href="#">various tests included in monographs as per I. P</a></li>
  <li><a href="#">A study of the following compounds with respect to their methods of preparation, assay, & pharmaceutical uses</a></li>
  <li><a href="#">sodium citrate</a></li>
  <li><a href="#">calcium carbonate</a></li>
  <li><a href="#">copper sulphate</a></li>
  <li><a href="#">light & heavy kaolin</a></li>
  <li><a href="#">ammonium chloride</a></li>
  <li><a href="#">ferrous gluconate</a></li>
</ul>

<li><a href="#">Isotopes</a></li>
<ul class="c">
  <li><a href="#">Isotopes- stable & radioactive, mode & rate of decay</a></li>
  <li><a href="#">Types & measurement of radioactivity</a></li>
  <li><a href="#">Radiopharmaceuticals & their diagnostic & therapeutic applications in pharmacy & medicine</a></li>
  <li><a href="#">125I</a></li>
  <li><a href="#">32P</a></li>
  <li><a href="#">51Cr</a></li>
  <li><a href="#">60Co</a></li>
  <li><a href="#">59Fe</a></li>
  <li><a href="#">99Tc-M</a></li>
  <li><a href="#">Radiocontrast media</a></li>
  <li><a href="#">use of BaSO4 in medicine</a></li>
  </ul>

<li><a href="#">Therapeutic classes of drugs</a></li>
<ul class="c">
  <li><a href="#">The following topics should be dealt with covering nomenclature [including stereochemical aspects], biological activity [including side & toxic effects ], mode of action, structure activity relationship [where ever applicable] & syntheses of reasonable molecules</a></li>
  <li><a href="#">Dentifrices, desensitizing agents, & anticaris agents</a></li>
  <li><a href="#">General anesthetics</a></li>
  <li><a href="#">Local anesthetics</a></li>
  <li><a href="#">Antiseptics, disinfectants, sterilants, & astringents</a></li>
  <li><a href="#">Purgatives, laxatives & antidiarrhoeal agents</a></li>
  <li><a href="#">Diagnostic agents</a></li>
  <li><a href="#">Coagulants, anticoagulants & plasma expanders</a></li>
    </ul>

<li><a href="#">Drug metabolism</a></li>
<ul class="c">
  <li><a href="#">Introduction to drug metabolism based on the functional groups.</a></li>
</ul>

<li><a href="#">Various classes of therapeutic agents</a></li>
<ul class="c">
  <li><a href="#">A detailed study of the following classes with respect to drug nomenclature, classification, physicochemical properties, mode of action [MOA], structure activity relationships [SAR], wherever applicable, synthesis of simple & prototype molecules, drug metabolism, therapeutic uses & side effects. Drug resistance, wherever applicable, should be covered in respective classes of drugs</a></li>
  <li><a href="#">Antiamoebic agents</a></li>
  <li><a href="#">Anthelmintic agents</a></li>
  <li><a href="#">Antibacterial sulpha drugs [only]</a></li>
  <li><a href="#">Quinolone antibacterials</a></li>
  <li><a href="#">Antimycobacterial drugs</a></li>
  <li><a href="#">Antifungal agents</a></li>
  <li><a href="#">Antiviral agents including HIV & anti-HIV drugs</a></li>
  <li><a href="#">Thyroid & anti thyroid drugs</a></li>
  <li><a href="#">Antiallergic agents</a></li>
  <li><a href="#">Antiulcer agents & Proton Pump Inhibitors</a></li>
  <li><a href="#">Hypoglycemic agents</a></li>
  <li><a href="#">Antimalerials</a></li>
</ul>

<li><a href="#">Different classes of therapeutic drugs</a></li>
<ul class="c">
  <li><a href="#">A detailed study of the following classes with respect to drug nomenclature, classification, physicochemical properties, mode of action [MOA] , structure activity relationships [SAR] , wherever applicable, synthesis of simple & prototype molecules, drug metabolism, therapeutic uses & side effects. Drug resistance, wherever applicable, should be covered in respective classes of drugs</a></li>
  <li><a href="#">Sedative-hypnotics</a></li>
  <li><a href="#">Antiepileptic agents</a></li>
  <li><a href="#">Neuroleptics</a></li>
  <li><a href="#">Anti-anxiety drugs</a></li>
  <li><a href="#">Diuretics</a></li>
  <li><a href="#">Antibiotics. Penicillins, cephalosporins & other beta- lactam antibiotics like imipenam & aztreonam. Beta-lactamase inhibitors such as clavulanic acid & sulbactum. Chloramphenicol. Tetracyclines. Aminoglycoside antibiotics. Macrolide antibiotics. Lincomycins. Polypeptide antibiotics. Anticancer antibiotics</a></li>
  <li><a href="#">Steroids. Corticosteroids [gluco- & mineralocorticoids] & anti-inflammatory steroids. Sex steroids. Male & female contraceptive agents. Anabolic steroids. Anticancer agents</a></li>
</ul>

<li><a href="#">Different classes of therapeutic drugs</a></li>
<ul class="c">
  <li><a href="#">A detailed study of the following classes with respect to drug nomenclature, classification, physicochemical properties, mode of action [MOA], biosynthesis, structure activity relationships [SAR], wherever applicable, synthesis of simple & prototype molecules, drug metabolism, therapeutic uses & side effects. Drug resistance, wherever applicable, in respective classes of drugs.</a></li>
  <li><a href="#">Narcotic [centrally acting] analgesics [analgetics]. Morphine & all its structural modifications [peripheral & nuclear]. Narcotic agonists & antagonists [dual & pure]. Non-narcotic analgesics [NSAIDS]. Difference between narcotic & non- narcotic agents.</a></li>
  <li><a href="#">Adrenergic drugs. Neurotransmitters & their role. General & specific adrenergic agonists & antagonists [up to alpha-2 & beta-2 only]</a></li>
  <li><a href="#">Cholinergic agents. Muscarinic & nicotinic cholinergic agonists & antagonists [up to M2 & N2]. Neuronal [transmission] blockers</a></li>
  <li><a href="#">Drugs used in neuromuscular disorders. Drugs used in the treatment of Parkinson's disease. Central & peripheral muscle relaxants</a></li>
  <li><a href="#">Hypertensive, antihypertensive, & antianginal agents</a></li>
  <li><a href="#">Eicosanoids. Prostaglandins, prostacyclins, & thromboxanes. Their biochemical role, biosynthesis, & inhibitors</a></li>
  <li><a href="#">Introduction to quantitative structure activity relationship. [QSAR]. Linear free energy relationship. Hammett's equation. Use of substituent constants such as G,
  a,  Es,  &  physicochemical  parameters  such  as  pKa,  partition  coefficient,  Rm,
  chemical shifts, molar refractivity, simple & valance molecular connectivity to
  indicate electronic effects, lipophillic effects, & steric effects. Introduction, methodology, advantages & disadvantages / limitations of Hansch analysis</a></li>
  <li><a href="#">Asymmetric synthesis. Chirality, chiral pool, sources of various naturally available chiral compounds. Eutomers, distomers, eudismic ratio. Enantioselectivity & enantiospecificity. Enantiomeric & diasteriomeric excess. Prochiral molecules. Asymmetric synthesis of captopril & propranolol</a></li>
  <li><a href="#">Combinatorial chemistry. Introduction & basic terminology. Databases & libraries. Solid phase synthesis technique. Types of supports & linkers, Wang, Rink, & dihydropyran derivatized linkers. Reactions involving these linkers. Manual parallel & automated parallel synthesis. Houghton's tea bag method, micromanipulation, recursive deconvolution. Mix & split method for the synthesis of tripeptides. Limitations of combinatorial synthesis. Introduction to throughput screening</a></li>
</ul>

</ul>

</ul>
</body>
</html>
